Clinical Trial Update: lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD [NA]

View source ↗

Summary

Clinical trial update from National Taiwan University Hospital on using an oral carbon adsorbent with or without probiotics to assess the therapeutic impact of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Peripheral Artery Disease

Drugs mentioned

• AST-120 (AST-120)
• Probiotic supplement

Snippet

Sponsor: National Taiwan University Hospital | Conditions: CKD, PAD | NA | Status: RECRUITING